High resolution computed tomography findings on the lung of early breast-cancer patients treated by postoperative breast irradiation with a hypofractionated radiotherapy schedule
Συγγραφέας
Plataniotis, G. A.; Theofanopoulou, M. E.; Sotiriadou, K.; Vlychou, M.; Fountoulis, G. A.; Fezoulidis, J.Ημερομηνία
2005Λέξη-κλειδί
Επιτομή
BACKGROUND: Hypofractionated breast radiotherapy (RT), although convenient for patients and health care systems, could have a negative impact on normal tissues such as lung. AIM: To evaluate radiation-induced lung toxicity in early breast-cancer patients treated by hypofractionated RT. SETTINGS AND DESIGN: We have been using the 42.5 Gy/16 fractions RT schedule since May 2003. As large fraction size is related to increased normal tissue toxicity we intended to investigate the possible radiation-induced lung toxicity to these patients, by performing high-resolution computed tomography (HRCT) 6 months after the completion of the treatment. MATERIALS AND METHODS: A group of 30 consecutive early breast-cancer patients (T1-2N0M0) have been treated by the above-mentioned RT schedule, using a pair of opposing tangential fields. The impact of chemotherapy and hormonotherapy and various breast size-related parameters on HRCT lung changes were investigated. Acute skin and breast tissue reactions were also recorded. STATISTICAL ANALYSIS: used Correlation of numerical variables was investigated by Pearson correlation coefficient. Logistic regression analysis was used to investigate correlation between HRCT findings (present vs absent) with other variables. RESULTS: Minimal HRCT findings were evident in 15/30 patients. These included small septal lines, linear and subpleural opacities and to a lesser extend, focal-ground glass opacification. The HRCT findings were positively correlated only to field separation (distance between the entrance points of the tangential beams on the breast) (H.R.=1.33, 95% CI: 1.013-1.75). CONCLUSIONS: The short 16-fraction RT schedule for early breast-cancer patients appears to have a minor effect on the underlying lung parenchyma.
Collections
Related items
Showing items related by title, author, creator and subject.
-
Lapatinib with whole brain radiotherapy in patients with brain metastases from breast and non-small cell lung cancer: a phase II study of the Hellenic Cooperative Oncology Group (HeCOG)
Christodoulou C., Kalogera-Fountzila A., Karavasilis V., Kouvatseas G., Papandreou C.N., Samantas E., Varaki K., Papadopoulos G., Bobos M., Rallis G., Razis E., Goudopoulou A., Kalogeras K.T., Syrigos K.N., Fountzilas G. (2017)Small molecules, mainly tyrosine kinase inhibitors, are currently used in various malignancies. Lapatinib, a dual inhibitor of EGFR/HER2 tyrosine kinases, has demonstrated effectiveness in brain metastases from HER2-overexpressing ... -
Evaluation of the irradiated volume of the heart and cardiac substructures after left breast radiotherapy
Gkantaifi A., Papadopoulos C., Spyropoulou D., Toumpourleka M., Iliadis G., Tsoukalas N., Kyrgias G., Tolia M. (2020)Backround/Aim: Adjuvant radiotherapy in patients with cancer of the left breast may lead to impaired cardiac function. The aim of our prospective study is to evaluate (i) doses to the irradiated volume of the heart and its ... -
An exploratory study of radiation dermatitis in breast cancer patients
Alexopoulou E., Katsila T., Tolia M., Tsoukalas N., Leontsinidis M., Kyrgias G., Kouloulias V., Patrinos G.P., Spyropoulou D., Kardamakis D. (2018)Background/Aim: Radiation dermatitis is observed in 95% of breast cancer patients receiving radiotherapy. The aim of this study was to explore the correlation between protein expression in tumor cells and the risk of ...